Back to Search
MANISHA CHINTALA, DMD
DMD
General Practice Dentistry
NPI: 1780459339Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
6001374-15(WI)
Research & Publications (18)
Development of a reference coastal wetland set in Southern New England (USA).
PMID 19224382·Environ Monit Assess·2010
7-preclinical
The influence of suburban land use on habitat and biotic integrity of coastal Rhode Island streams.
PMID 17564795·Environ Monit Assess·2008
8-other
Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity.
PMID 18447380·J Med Chem·2008
7-preclinical
Basic and translational research on proteinase-activated receptors: antagonism of the proteinase-activated receptor 1 for thrombin, a novel approach to antiplatelet therapy for atherothrombotic disease.
PMID 19098390·J Pharmacol Sci·2008
7-preclinical
Himbacine derived thrombin receptor (PAR-1) antagonists: SAR of the pyridine ring.
PMID 17574850·Bioorg Med Chem Lett·2007
7-preclinical
Heterotricyclic himbacine analogs as potent, orally active thrombin receptor (protease activated receptor-1) antagonists.
PMID 17854166·J Med Chem·2007
7-preclinical
Himbacine derived thrombin receptor antagonists: discovery of a new tricyclic core.
PMID 17490877·Bioorg Med Chem Lett·2007
7-preclinical
Metabolism-based identification of a potent thrombin receptor antagonist.
PMID 17201416·J Med Chem·2007
7-preclinical
Discovery and synthesis of a novel series of quinoline-based thrombin receptor (PAR-1) antagonists.
PMID 16380251·Bioorg Med Chem Lett·2006
7-preclinical
Discovery of potent orally active thrombin receptor (protease activated receptor 1) antagonists as novel antithrombotic agents.
PMID 16161991·J Med Chem·2005
7-preclinical
Optimization of purine based PDE1/PDE5 inhibitors to a potent and selective PDE5 inhibitor for the treatment of male ED.
PMID 15837326·Bioorg Med Chem Lett·2005
7-preclinical
SAR development of polycyclic guanine derivatives targeted to the discovery of a selective PDE5 inhibitor for treatment of erectile dysfunction.
PMID 14980684·Bioorg Med Chem Lett·2004
8-other
Comparison of in vitro-cultured and wild-type Perkinsus marinus. III. Fecal elimination and its role in transmission.
PMID 12465879·Dis Aquat Organ·2002
4-observational
Comparison of in vitro-cultured and wild-type Perkinsus marinus. II. Dosing methods and host response.
PMID 12465878·Dis Aquat Organ·2002
4-observational
Comparison of in vitro-cultured and wild-type Perkinsus marinus. I. Pathogen virulence.
PMID 12465877·Dis Aquat Organ·2002
4-observational
Design and synthesis of xanthine analogues as potent and selective PDE5 inhibitors.
PMID 12372521·Bioorg Med Chem Lett·2002
4-observational
Quantitative screening and matrix effect studies of drug discovery compounds in monkey plasma using fast-gradient liquid chromatography/tandem mass spectrometry.
PMID 11746920·Rapid Commun Mass Spectrom·2001
7-preclinical
Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs.
PMID 11413167·J Clin Invest·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6213 MIDDLETON SPRINGS DR, SUITE 104
MIDDLETON, WI 53562 - Phone
- (608) 831-0467
Quick Facts
- NPI
- 1780459339
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 18
Are you this provider?
Claim Your Profile